Cost-effectiveness of Monoclonal Antibodies to Gram-negative Endotoxin in the Treatment of Gram-negative Sepsis in ICU Patients

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1977 • 2,113 citations

Clinical decision analysis

2005 • 1,645 citations

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

1991 • 1,611 citations

Septic Shock in Humans

1990 • 1,170 citations

The Distinction Between Cost and Charges

1982 • 1,090 citations

Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli

1982 • 1,062 citations

The Markov Process in Medical Prognosis

1983 • 954 citations

Probabilistic Sensitivity Analysis Using Monte Carlo Simulation

1985 • 820 citations

A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

1991 • 741 citations

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

1989 • 709 citations

PROBABILITY AND STATISTICS

1985 • 581 citations

A convenient approximation of life expectancy (the “DEALE”)

1982 • 472 citations

A convenient approximation of life expectancy (the “DEALE”)

1982 • 418 citations

Decision Analysis: A Progress Report

1987 • 267 citations

Care of Patients with a Low Probability of Acute Myocardial Infarction

1984 • 250 citations

National estimates of intensive care utilization and costs

1990 • 250 citations

Anti-Endotoxin Monoclonal Antibodies

1992 • 235 citations

Patterns of Resource Consumption in Medical Intensive Care*

1991 • 204 citations

Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation

1986 • 196 citations

Survival, Hospitalization Charges and Follow-up Results in Critically Ill Patients

1976 • 191 citations

Hospital Cost Containment in the 1980s

1991 • 162 citations

Results and Costs of Intensive Care

1977 • 112 citations

Cost-effectiveness of HA-1A Monoclonal Antibody for Gram-Negative Sepsis

1991 • 96 citations

Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity

1987 • 66 citations

Technology under Medicare Diagnosis-related Groups Prospective Payment

1985 • 61 citations

Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients

1988 • 54 citations

Medicare Prospective Payment and the Use of Medical Technologies in Hospitals

1988 • 53 citations

A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

1987 • 53 citations

The Impact of New Cloning Techniques on the Diagnosis and Treatment of Infectious Diseases

1984 • 52 citations

The High Cost of Acute Health Care: A Review of Escalating Costs and Limitations of Such Exposure in Intensive Care Units

1987 • 30 citations

The Multiple Organ Failure Syndrome

1990 • 29 citations

Changes in Physician Attitudes Toward Limiting Care of Critically Ill Patients

1991 • 26 citations

Reimbursement for intensive care services under diagnosis-related groups

1988 • 25 citations

Antiendotoxin Monoclonal Antibodies

1994 • 19 citations

The Variation in Hospital Charges: A Problem in Determining Cost/Benefit for Cardiac Surgery

1977 • 18 citations

Impact of Diagnosis-Related Groups' Prospective Payment on Utilization of Medical Intensive Care

1988 • 11 citations

Criteria for use of antiendotoxin monoclonal antibodies (HA-1A and E5) in adult and pediatric inpatients.

1992 • 1 citations